Literature DB >> 3047537

Autoantibodies and circulating immune complexes in subjects infected with human immunodeficiency virus.

R Mayer-Siuta1, L B Keil, V A DeBari.   

Abstract

We wish to report the results of a retrospective study of patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex (ARC) as well as a group of asymptomatic human immunodeficiency virus (HIV)-infected individuals, in whom we examined markers of systemic autoimmune disease including anti-cell antibodies, immunoglobulin (Ig) and complement (C3 and C4) profiles as well as circulating immune complexes (CIC). Antibodies to cytoplasmic (but not nuclear) antigens were significantly elevated in the AIDS and ARC groups when compared with a population of normal individuals (for AIDS, P = 0.0002 vs. control; for ARC, P = 0.0004 vs. control). The non-AIDS/ARC, HIV+ group did not demonstrate significance (P = 0.054). Each of the three study groups also demonstrated increased Ig (P less than 0.05 for each immunoglobulin class). CIC, as determined by a Clq-binding enzyme immunoassay, were higher in all three study groups (P less than 0.05) when compared with controls. C3 and C4 were not significantly lower than control subjects (P greater than 0.05), but C4 did demonstrate a significant (P = 0.01) inverse correlation with CIC. These findings strengthen the hypothesized autoimmune aspect of AIDS and ARC, and extend this concept to include HIV-infected individuals without frank disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3047537     DOI: 10.1007/BF00211218

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  13 in total

1.  AIDS: from immunity to infection to autoimmunity. A comprehensive hypothesis of the pathogenesis of the disease.

Authors:  J L Lepe-Zuniga; P W Mansell
Journal:  AIDS Res       Date:  1986

2.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

3.  The use of solid phase Clq and horseradish peroxidase-conjugated goat anti-IgG for the detection of immune complexes in human serum.

Authors:  C Wehler; J M Andrews; D H Bing
Journal:  Mol Immunol       Date:  1981-03       Impact factor: 4.407

4.  A rate nephelometer for measuring specific proteins by immunoprecipitin reactions.

Authors:  J C Sternberg
Journal:  Clin Chem       Date:  1977-08       Impact factor: 8.327

5.  KB cells for antinuclear antibody determination: comparison with HEp-2 cells and the Crithidia luciliae assay.

Authors:  L B Keil; V A DeBari; M A Needle
Journal:  Diagn Immunol       Date:  1984

6.  Opportunistic infections and Kaposi's sarcoma among Haitians: evidence of a new acquired immunodeficiency state.

Authors:  A E Pitchenik; M A Fischl; G M Dickinson; D M Becker; A M Fournier; M T O'Connell; R M Colton; T J Spira
Journal:  Ann Intern Med       Date:  1983-03       Impact factor: 25.391

7.  Circulating immune complexes in patients with acquired immune deficiency syndrome contain the AIDS-associated retrovirus.

Authors:  W J Morrow; M Wharton; R B Stricker; J A Levy
Journal:  Clin Immunol Immunopathol       Date:  1986-09

8.  Immunoglobulin bound to platelets as immune complexes or specific antibody in specimens from acquired immunodeficiency syndrome and immune thrombocytopenic purpura.

Authors:  H Daugharty; T L Chorba; D W Personette; K V Savoca; V MacDonald
Journal:  Diagn Immunol       Date:  1985

9.  Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome.

Authors:  H C Lane; H Masur; L C Edgar; G Whalen; A H Rook; A S Fauci
Journal:  N Engl J Med       Date:  1983-08-25       Impact factor: 91.245

10.  Immune complexes in the acquired immunodeficiency syndrome (AIDS): relationship to disease manifestation, risk group, and immunologic defect.

Authors:  J S McDougal; M Hubbard; J K Nicholson; B M Jones; R C Holman; J Roberts; D B Fishbein; H W Jaffe; J E Kaplan; T J Spira
Journal:  J Clin Immunol       Date:  1985-03       Impact factor: 8.317

View more
  3 in total

1.  Serial study of CD5+ and CD5- B cell subpopulations in 335 HIV seropositive patients.

Authors:  F Vuillier; D Scott-Algara; P Tortevoye; G Pialoux; G Dighiero
Journal:  Clin Exp Immunol       Date:  1991-09       Impact factor: 4.330

2.  C3b/iC3b deposition on Streptococcus pneumoniae is not affected by HIV infection.

Authors:  Catherine Hyams; Jerry C H Tam; Jeremy S Brown; Stephen B Gordon
Journal:  PLoS One       Date:  2010-01-26       Impact factor: 3.240

Review 3.  Retroviruses and autoimmune rheumatic diseases.

Authors:  J R Kalden; S Gay
Journal:  Clin Exp Immunol       Date:  1994-10       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.